Harnessing The Potential Of Gene Therapies: Innovations And Improvements In Viral Gene Therapy

Learn how to overcome barriers in viral gene therapy development and manufacturing for rare diseases. While these therapies hold immense promise, their high costs and limited commercial viability can impede progress. This webinar helps connect you with experts to explore the latest innovations and improvements.

Steven Gray, Professor at UT Southwestern, presents the potential of AAV gene therapy as a platform for treating multiple genetic neurological diseases and share strategies for more efficient and affordable translational studies. Additionally, Eric Talley, Senior Technical Sales Specialist at Aldevron, discusses advancements in viral gene therapy manufacturing that are addressing key challenges.

This session covers:

• Viral gene therapy approaches for genetic conditions
• The impact of regulatory pathways and technological innovations on study efficiency and cost reduction
• Manufacturing solutions that are facilitating the development of these vital therapies